Customer publications

To see publications by product, please select product: B-200 – B-205 – B-260 – B-264 – B-270 – B-272 – B-277 – B-280 – B-288 – B-289 – B-301 – B-305 – B-355 – B-405 – B-605 – B-622 – B-705 – B-772 – B-773 – B-1005 – M-120 – M-130 – M-140 – M-147 – M-150 – M-180 – M-190 – M-220 – M-600 – X-287

2021

1. T. E. Assafa, S. Nandi, D. Śmiłowicz, L. Galazzo, M. Teucher, C. Elsner, S. Pütz, S. Bleicken, A. Y. Robin, D. Westphal, I. Uson, R. Stoll, P. E. Czabotar, N. Metzler-Nolte, E. Bordignon. Biophysical Characterization of Pro-apoptotic BimBH3 Peptides Reveals an Unexpected Capacity for Self-Association

   Structure, vol. 29, 2021, pp. 114-124.e3
   

2. H. Baudhuin, P. J. Van Bockstal, T. De Beer, I. Vaneycken, J. Bridoux, G. Raes, V. Caveliers, M. Keyaerts, N. Devoogdt, T. Lahoutte, C. Xavier. Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for ⁶⁸Ga-labeling

   Eur J Pharm Biopharm, vol. 166, 2021, pp. 194-204
   

3. I. J. G. Burvenich, Y. W. Goh, N. Guo, H. K. Gan, A. Rigopoulos, D. Cao, Z. Liu, U. Ackermann, C. W. Wichmann, A. F. McDonald, N. Huynh, G. J. O\'Keefe, S. J. Gong, F. E. Scott, L. Li, W. Geng, A. Zutshi, Y. Lan, A. M. Scott. Radiolabelling and preclinical characterization of (89)Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa

   Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 3075-3088
   

4. Q. Cao, Q. Huang, Y. A. Wang, C. Li. Abraxane-induced bone marrow CD11b(+) myeloid cell depletion in tumor-bearing mice is visualized by μPET-CT with ⁶⁴Cu-labeled anti-CD11b and prevented by anti-CSF-1

   Theranostics, vol. 11, 2021, pp. 3527-3539
   

5. A. Cavaliere, S. Sun, S. Lee, J. Bodner, Z. Li, Y. Huang, S. L. Moores, B. Marquez-Nostra. Development of ⁸⁹ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer

   Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 383-394
   

6. M. Chomet, M. Schreurs, M. J. Bolijn, M. Verlaan, W. Beaino, K. Brown, A. J. Poot, A. D. Windhorst, H. Gill, J. Marik, S. Williams, J. Cowell, G. Gasser, T. L. Mindt, Gams van Dongen, D. J. Vugts. Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical ⁸⁹Zr-immuno-PET

   Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 694-707
   

7. N. Dammes, M. Goldsmith, S. Ramishetti, J. L. J. Dearling, N. Veiga, A. B. Packard, D. Peer. Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics

   Nat Nanotechnol, vol. 16, 2021, pp. 1030-1038
   

8. P. Diebolder, C. Mpoy, J. Scott, T. T. Huynh, R. Fields, D. Spitzer, N. Bandara, B. E. Rogers. Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44

   J Nucl Med, vol. 62, 2021, pp. 137-143
   

9. T. V. F. Esposito, H. Stütz, C. Rodríguez-Rodríguez, M. Bergamo, L. Charles, R. Geczy, C. Blackadar, J. P. Kutter, K. Saatchi, U. O. Häfeli. Preparation of Heat-Denatured Macroaggregated Albumin for Biomedical Applications Using a Microfluidics Platform

   ACS Biomater Sci Eng, vol. 7, 2021, pp. 2823-2834
   

10. S. Fa, K. Adachi, Y. Nagata, K. Egami, K. Kato, T. Ogoshi. Pre-regulation of the planar chirality of pillar[5]arenes for preparing discrete chiral nanotubes

    Chem Sci, vol. 12, 2021, pp. 3483-3488
    

11. C. A. Ferreira, L. Kang, C. Li, A. Kamkaew, K. E. Barrett, E. Aluicio-Sarduy, Y. Yang, J. W. Engle, D. Jiang, W. Cai. ImmunoPET of the differential expression of CD146 in breast cancer

    Am J Cancer Res, vol. 11, 2021, pp. 1586-1599
    

12. Y. Funase, E. Nakamura, M. Kajita, Y. Saito, S. Oshikiri, M. Kitano, M. Tokura, A. Hino, T. Uehara. Preclinical Characterization of the Radioimmunoconjugate ¹¹¹In or ⁹⁰Y-FF-21101 Against a P-Cadherin-Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate

    J Nucl Med, vol. 62, 2021, pp. 232-239
    

13. A. Ghai, A. Zheleznyak, M. Mixdorf, J. O\'Neal, J. Ritchey, M. Rettig, J. DiPersio, M. Shokeen, S. Achilefu. Development of [⁸⁹Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 1302-1311
    

14. A. Gonzalez-Junca, O. Reiners, L. D. Borrero-Garcia, D. Beckford-Vera, A. A. Lazar, W. Chou, S. Braunstein, H. VanBrocklin, B. L. Franc, M. H. Barcellos-Hoff. Positron Emission Tomography Imaging of Functional Transforming Growth Factor β (TGFβ) Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors

    Int J Radiat Oncol Biol Phys, vol. 109, 2021, pp. 527-539
    

15. L. Hao, N. Rohani, R. T. Zhao, E. M. Pulver, H. Mak, O. J. Kelada, H. Ko, H. E. Fleming, F. B. Gertler, S. N. Bhatia. Microenvironment-triggered multimodal precision diagnostics

    Nat Mater, vol. 20, 2021, pp. 1440-1448
    

16. K. E. Henry, K. N. Mack, V. L. Nagle, M. Cornejo, A. O. Michel, I. L. Fox, M. Davydova, T. R. Dilling, N. Pillarsetty, J. S. Lewis. ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

    Mol Cancer Ther, vol. 20, 2021, pp. 2026-2034
    

17. K. E. Henry, T. M. Shaffer, K. N. Mack, J. Ring, A. Ogirala, S. Klein-Scory, C. Eilert-Micus, W. Schmiegel, T. Bracht, B. Sitek, M. Clyne, C. J. Reid, B. Sipos, J. S. Lewis, H. Kalthoff, J. Grimm. Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer

    J Nucl Med, vol. 62, 2021, pp. 1384-1390
    

18. Y. Huang, Z. Yang, F. Li, H. Zhao, C. Li, N. Yu, D. J. Hamilton, Z. Li. ⁶⁴Cu/¹⁷⁷Lu-DOTA-diZD, a Small-Molecule-Based Theranostic Pair for Triple-Negative Breast Cancer

    J Med Chem, vol. 64, 2021, pp. 2705-2713
    

19. C. Hutton, F. Heider, A. Blanco-Gomez, A. Banyard, A. Kononov, X. Zhang, S. Karim, V. Paulus-Hock, D. Watt, N. Steele, S. Kemp, E. K. J. Hogg, J. Kelly, R. F. Jackstadt, F. Lopes, M. Menotti, L. Chisholm, A. Lamarca, J. Valle, O. J. Sansom, C. Springer. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity

    Cancer Cell, vol. 39, 2021, pp. 1227-1244.e20
    

20. L. Kang, C. Li, Z. T. Rosenkrans, J. W. Engle, R. Wang, D. Jiang, X. Xu, W. Cai. Noninvasive Evaluation of CD20 Expression Using ⁶⁴Cu-Labeled F(ab\')(2) Fragments of Obinutuzumab in Lymphoma

    J Nucl Med, vol. 62, 2021, pp. 372-378
    

21. A. Koudrina, E. M. McConnell, J. A. Zurakowski, G. O. Cron, S. Chen, E. C. Tsai, M. C. DeRosa. Exploring the Unique Contrast Properties of Aptamer-Gadolinium Conjugates in Magnetic Resonance Imaging for Targeted Imaging of Thrombi

    ACS Appl Mater Interfaces, vol. 13, 2021, pp. 9412-9424
    

22. M. Krekorian, G. G. W. Sandker, K. R. G. Cortenbach, O. Tagit, N. K. van Riessen, R. Raavé, M. Srinivas, C. G. Figdor, S. Heskamp, Ehjg Aarntzen. Characterization of Intrinsically Radiolabeled Poly(lactic-co-glycolic acid) Nanoparticles for ex Vivo Autologous Cell Labeling and in Vivo Tracking

    Bioconjug Chem, vol. 32, 2021, pp. 1802-1811
    

23. S. G. Lee, T. M. Kalidindi, H. Lou, K. Gangangari, B. Punzalan, A. Bitton, C. J. Lee, H. A. Vargas, S. Park, L. Bodei, M. G. Kharas, V. K. Singh, N. V. Kishore Pillarsetty, S. M. Larson. γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs

    J Nucl Med, vol. 62, 2021, pp. 584-590
    

24. M. Li, W. Wei, T. E. Barnhart, D. Jiang, T. Cao, K. Fan, J. W. Engle, J. Liu, W. Chen, W. Cai. ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 2737-2748
    

25. A. A. Lo, J. Johnston, J. Li, D. Mandikian, M. Hristopoulos, R. Clark, D. Nickles, W. C. Liang, K. Hötzel, D. Dunlap, T. Pham, H. Cai, M. Ovacik, D. Bravo-Perez, E. Mai, D. Slaga, D. Ellerman, J. Ziai, K. Totpal, G. Lee, C. A. Boswell. Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer

    Mol Cancer Ther, vol. 20, 2021, pp. 716-725
    

26. W. Lu, Y. Cong, D. Yang, D. Chen, G. Yang, Y. Wang, M. E. Van Dort, B. D. Ross, A. P. Mazar, B. B. Chu, H. Hong. Engineered Antibody Fragment against the Urokinase Plasminogen Activator for Fast Delineation of Triple-Negative Breast Cancer by Positron Emission Tomography

    Mol Pharm, vol. 18, 2021, pp. 1690-1698
    

27. T. Ma, H. Ryu, M. McGregor, B. Babcock, J. Neidleman, G. Xie, A. F. George, J. Frouard, V. Murray, G. Gill, E. Ghosn, E. W. Newell, S. A. Lee, N. R. Roan. Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence

    J Immunol, vol. 207, 2021, pp. 1344-1356
    

28. K. E. Martin, A. G. Cosby, E. Boros. Multiplex and In Vivo Optical Imaging of Discrete Luminescent Lanthanide Complexes Enabled by In Situ Cherenkov Radiation Mediated Energy Transfer

    J Am Chem Soc, vol. 143, 2021, pp. 9206-9214
    

29. M. Minnix, V. Adhikarla, E. Caserta, E. Poku, R. Rockne, J. E. Shively, F. Pichiorri. Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model

    J Nucl Med, vol. 62, 2021, pp. 795-801
    

30. M. Minnix, L. Li, P. J. Yazaki, A. D. Miller, J. Chea, E. Poku, A. Liu, J. Y. C. Wong, R. C. Rockne, D. Colcher, J. E. Shively. TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using ²²⁵Ac-Labeled DOTAylated-huCC49 Antibody

    J Nucl Med, vol. 62, 2021, pp. 55-61
    

31. V. L. Nagle, K. E. Henry, C. A. J. Hertz, M. S. Graham, C. Campos, L. F. Parada, N. Pandit-Taskar, A. Schietinger, I. K. Mellinghoff, J. S. Lewis. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with ⁶⁴Cu-NOTA-anti-CD8 PET

    Clin Cancer Res, vol. 27, 2021, pp. 1958-1966
    

32. A. Nomani, G. Li, S. Yousefi, S. Wu, O. M. Malekshah, S. K. Nikkhoi, M. Pourfathi, R. Rizi, A. Hatefi. Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI

    J Control Release, vol. 337, 2021, pp. 132-143
    

33. K. Ogawa, H. Echigo, K. Mishiro, S. Hirata, K. Washiyama, Y. Kitamura, K. Takahashi, K. Shiba, S. Kinuya. ⁶⁸Ga- and ²¹¹At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides

    Mol Pharm, vol. 18, 2021, pp. 3553-3562
    

34. P. M. R. Pereira, J. Norfleet, J. S. Lewis, F. E. Escorcia. Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

    J Nucl Med, vol. 62, 2021, pp. 366-371
    

35. S. Prabhu, H. Deng, T. L. Cross, S. H. Shahoei, C. J. Konopka, N. Gonzalez Medina, C. C. Applegate, M. A. Wallig, L. W. Dobrucki, E. R. Nelson, A. M. Smith, K. S. Swanson. Nanocarriers targeting adipose macrophages increase glucocorticoid anti-inflammatory potency to ameliorate metabolic dysfunction

    Biomater Sci, vol. 9, 2021, pp. 506-518
    

36. S. Qin, Y. Yu, H. Guan, Y. Yang, F. Sun, Y. Sun, J. Zhu, L. Xing, J. Yu, X. Sun. A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with ⁶⁸Ga-labeled PD-L1 targeted nanobody

    Aging (Albany NY), vol. 13, 2021, pp. 13006-13022
    

37. S. M. Rathmann, A. R. Genady, N. Janzen, V. Anipindi, S. Czorny, A. F. Rullo, S. Sadeghi, J. F. Valliant. A Versatile Platform for the Development of Radiolabeled Antibody-Recruiting Small Molecules

    Mol Pharm, vol. 18, 2021, pp. 2647-2656
    

38. J. Ren, M. Xu, J. Chen, J. Ding, P. Wang, L. Huo, F. Li, Z. Liu. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a ¹⁷⁷Lu-labeled αPD-L1 antibody

    Theranostics, vol. 11, 2021, pp. 304-315
    

39. M. R. Rudnick, I. M. Wahba, A. K. Leonberg-Yoo, D. Miskulin, H. I. Litt. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review

    Am J Kidney Dis, vol. 77, 2021, pp. 517-528
    

40. B. H. Santich, S. M. Cheal, M. Ahmed, M. R. McDevitt, O. Ouerfelli, G. Yang, D. R. Veach, E. K. Fung, M. Patel, D. Burnes Vargas, A. A. Malik, H. F. Guo, P. B. Zanzonico, S. Monette, A. O. Michel, C. M. Rudin, S. M. Larson, N. K. Cheung. A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy

    Clin Cancer Res, vol. 27, 2021, pp. 532-541
    

41. S. M. Sarrett, O. Keinänen, E. J. Dayts, G. Dewaele-Le Roi, C. Rodriguez, K. E. Carnazza, B. M. Zeglis. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy

    Nat Protoc, vol. 16, 2021, pp. 3348-3381
    

42. I. Schulien, J. Kemming, V. Oberhardt, K. Wild, L. M. Seidel, S. Killmer, Sagar, F. Daul, M. Salvat Lago, A. Decker, H. Luxenburger, B. Binder, D. Bettinger, O. Sogukpinar, S. Rieg, M. Panning, D. Huzly, M. Schwemmle, G. Kochs, C. F. Waller, A. Nieters, D. Duerschmied, F. Emmerich, H. E. Mei, A. R. Schulz, S. Llewellyn-Lacey, D. A. Price, T. Boettler, B. Bengsch, R. Thimme, M. Hofmann, C. Neumann-Haefelin. Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells

    Nat Med, vol. 27, 2021, pp. 78-85
    

43. M. Schwabenland, H. Salié, J. Tanevski, S. Killmer, M. S. Lago, A. E. Schlaak, L. Mayer, J. Matschke, K. Püschel, A. Fitzek, B. Ondruschka, H. E. Mei, T. Boettler, C. Neumann-Haefelin, M. Hofmann, A. Breithaupt, N. Genc, C. Stadelmann, J. Saez-Rodriguez, P. Bronsert, K. P. Knobeloch. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions

    Immunity, vol. 54, 2021, pp. 1594-1610.e11
    

44. T. Shaffer, A. Natarajan, S. S. Gambhir. PET Imaging of TIGIT Expression on Tumor-Infiltrating Lymphocytes

    Clin Cancer Res, vol. 27, 2021, pp. 1932-1940
    

45. F. Simonetta, I. S. Alam, J. K. Lohmeyer, B. Sahaf, Z. Good, W. Chen, Z. Xiao, T. Hirai, L. Scheller, P. Engels, O. Vermesh, E. Robinson, T. Haywood, A. Sathirachinda, J. Baker, M. B. Malipatlolla, L. M. Schultz, J. Y. Spiegel, J. T. Lee, D. B. Miklos, C. L. Mackall, S. S. Gambhir, R. S. Negrin. Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET

    Clin Cancer Res, vol. 27, 2021, pp. 1058-1068
    

46. S. L. Slania, D. Das, A. Lisok, Y. Du, Z. Jiang, R. C. Mease, S. P. Rowe, S. Nimmagadda, X. Yang, M. G. Pomper. Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules

    J Med Chem, vol. 64, 2021, pp. 4059-4070
    

47. D. Sonanini, C. M. Griessinger, B. F. Schörg, P. Knopf, K. Dittmann, M. Röcken, B. J. Pichler, M. Kneilling. Low-dose total body irradiation facilitates antitumoral Th1 immune responses

    Theranostics, vol. 11, 2021, pp. 7700-7714
    

48. M. Tognetti, A. Gabor, M. Yang, V. Cappelletti, J. Windhager, O. M. Rueda, K. Charmpi, E. Esmaeilishirazifard, A. Bruna, N. de Souza, C. Caldas, A. Beyer, P. Picotti, J. Saez-Rodriguez, B. Bodenmiller. Deciphering the signaling network of breast cancer improves drug sensitivity prediction

    Cell Syst, vol. 12, 2021, pp. 401-418.e12
    

49. C. Wang, Y. Chen, Y. N. Hou, Q. Liu, D. Zhang, H. Zhao, Y. Zhang, S. An, L. Li, J. Hou, G. Huang, J. Liu, Y. J. Zhao, W. Wei. ImmunoPET imaging of multiple myeloma with ⁶⁸Ga-NOTA-Nb1053

    Eur J Nucl Med Mol Imaging, vol. 48, 2021, pp. 2749-2760
    

50. C. Wang, D. Cheng, N. Jalali Motlagh, E. G. Kuellenberg, G. R. Wojtkiewicz, S. P. Schmidt, R. Stocker, J. W. Chen. Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity

    J Med Chem, vol. 64, 2021, pp. 5874-5885
    

51. S. Wang, J. Li, J. Hua, Y. Su, D. R. Beckford-Vera, W. Zhao, M. Jayaraman, T. L. Huynh, N. Zhao, Y. H. Wang, Y. Huang, F. Qin, S. Shen, D. Gioeli, R. Dreicer, R. Sriram, E. A. Egusa, J. Chou, F. Y. Feng, R. Aggarwal, M. J. Evans, Y. Seo, B. Liu, R. R. Flavell, J. He. Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

    Clin Cancer Res, vol. 27, 2021, pp. 1305-1315
    

52. Y. Wang, H. Ni, S. Zhou, K. He, Y. Gao, W. Wu, M. Wu, Z. Wu, X. Qiu, Y. Zhou, B. Chen, D. Pan, C. Huang, M. Li, Y. Bian, M. Yang, L. Miao, J. Liu. Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity

    Cancer Immunol Immunother, vol. 70, 2021, pp. 365-376
    

53. N. R. Wong, J. Mohan, B. J. Kopecky, S. Guo, L. Du, J. Leid, G. Feng, I. Lokshina, O. Dmytrenko, H. Luehmann, G. Bajpai, L. Ewald, L. Bell, N. Patel, A. Bredemeyer, C. J. Weinheimer, J. M. Nigro, A. Kovacs, S. Morimoto, P. O. Bayguinov, M. R. Fisher, W. T. Stump, M. Greenberg, J. A. J. Fitzpatrick, S. Epelman, D. Kreisel, R. Sah, Y. Liu, H. Hu, K. J. Lavine. Resident cardiac macrophages mediate adaptive myocardial remodeling

    Immunity, vol. 54, 2021, pp. 2072-2088.e7
    

54. J. Yang, C. Zhao, J. Lim, L. Zhao, R. L. Tourneau, Q. Zhang, D. Dobson, S. Joshi, J. Pang, X. Zhang, S. Pal, C. Andreou, H. Zhang, M. F. Kircher, H. Schmitthenner. Structurally symmetric near-infrared fluorophore IRDye78-protein complex enables multimodal cancer imaging

    Theranostics, vol. 11, 2021, pp. 2534-2549
    

55. M. Zhang, J. Ye, Z. Xie, Y. Yan, J. Wang, X. Chen. Optimization of Enzymolysis Clearance Strategy To Enhance Renal Clearance of Radioligands

    Bioconjug Chem, vol. 32, 2021, pp. 2108-2116
    

56. Y. Zhang, X. Han, G. Nie. Responsive and activable nanomedicines for remodeling the tumor microenvironment

    Nat Protoc, vol. 16, 2021, pp. 405-430
    

2020

57. A. K. Abu-Alfa. Use of Gadolinium-Based Contrast Agents in Kidney Disease Patients: Time for Change

    Am J Kidney Dis, vol. 76, 2020, pp. 436-439
    

58. M. Agnoletti, C. Rodríguez-Rodríguez, S. N. Kłodzińska, T. V. F. Esposito, K. Saatchi, H. Mørck Nielsen, U. O. Häfeli. Monosized Polymeric Microspheres Designed for Passive Lung Targeting: Biodistribution and Pharmacokinetics after Intravenous Administration

    ACS Nano, vol. 14, 2020, pp. 6693-6706
    

59. I. S. Alam, F. Simonetta, L. Scheller, A. T. Mayer, S. Murty, O. Vermesh, T. W. Nobashi, J. K. Lohmeyer, T. Hirai, J. Baker, K. H. Lau, R. Negrin, S. S. Gambhir. Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease

    Cancer Res, vol. 80, 2020, pp. 4780-4790
    

60. R. Balhorn, M. C. Balhorn. Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers

    Oncotarget, vol. 11, 2020, pp. 3315-3349
    

61. D. R. Beckford Vera, S. D. Fontaine, H. F. VanBrocklin, B. R. Hearn, R. Reid, G. W. Ashley, D. V. Santi, B. Bengsch, T. Ohtani, O. Khan, M. Setty, S. Manne, S. O'Brien, P. F. Gherardini, R. S. Herati, A. C. Huang, K. M. Chang, E. W. Newell, N. Bovenschen, D. Pe'er, S. M. Albelda, E. J. Wherry. PET Imaging of the EPR Effect in Tumor Xenografts Using Small 15 nm Diameter Polyethylene Glycols Labeled with Zirconium-89

    Mol Cancer Ther, vol. 19, 2020, pp. 673-679
    

62. E. Berg, H. Gill, J. Marik, A. Ogasawara, S. Williams, G. van Dongen, D. Vugts, S. R. Cherry, A. F. Tarantal. Total-Body PET and Highly Stable Chelators Together Enable Meaningful ⁸⁹Zr-Antibody PET Studies up to 30 Days After Injection

    J Nucl Med, vol. 61, 2020, pp. 453-460
    

63. C. C. Chen, D. Y. Chang, J. J. Li, H. W. Chan, J. T. Chen, C. H. Chang, R. S. Liu, C. A. Chang, C. L. Chen, H. E. Wang. Investigation of biodistribution and tissue penetration of PEGylated gold nanostars and their application for photothermal cancer treatment in tumor-bearing mice

    J Mater Chem B, vol. 8, 2020, pp. 65-77
    

64. Z. Chen, M. Chen, Y. Cheng, T. Kowada, J. Xie, X. Zheng, J. Rao. Exploring the Condensation Reaction between Aromatic Nitriles and Amino Thiols To Optimize In Situ Nanoparticle Formation for the Imaging of Proteases and Glycosidases in Cells

    Angew Chem Int Ed Engl, vol. 59, 2020, pp. 3272-3279
    

65. M. Chomet, M. Schreurs, M. Nguyen, B. Howng, R. Villanueva, M. Krimm, O. Vasiljeva, Gams van Dongen, D. J. Vugts. The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by ⁸⁹Zr-immuno-PET in xenograft bearing mice

    Theranostics, vol. 10, 2020, pp. 5815-5828
    

66. C. Christensen, L. K. Kristensen, M. Z. Alfsen, C. H. Nielsen, A. Kjaer. Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody

    Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 1302-1313
    

67. A. Corroyer-Dulmont, S. Valable, N. Falzone, A. M. Frelin-Labalme, O. Tietz, J. Toutain, M. S. Soto, D. Divoux, L. Chazalviel, E. A. Pérès, N. R. Sibson, K. A. Vallis, M. Bernaudin. VCAM-1 targeted alpha-particle therapy for early brain metastases

    Neuro Oncol, vol. 22, 2020, pp. 357-368
    

68. W. Dawicki, K. J. H. Allen, R. Garg, E. M. Geoghegan, M. S. Berger, D. L. Ludwig, E. Dadachova. Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy

    Oncotarget, vol. 11, 2020, pp. 3571-3581
    

69. J. M. de Gooyer, F. M. K. Elekonawo, D. L. Bos, R. S. van der Post, A. Pèlegrin, B. Framery, F. Cailler, A. L. Vahrmeijer, J. H. W. de Wilt, M. Rijpkema. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using ¹¹¹In-Labeled SGM-101

    Clin Cancer Res, vol. 26, 2020, pp. 5934-5942
    

70. D. N. Dorst, M. Rijpkema, M. Boss, B. Walgreen, M. M. A. Helsen, D. L. Bos, M. Brom, C. Klein, P. Laverman, P. M. van der Kraan, M. Gotthardt, M. I. Koenders, M. Buitinga. Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis

    Rheumatology (Oxford), vol. 59, 2020, pp. 3952-3960
    

71. L. Droctové, M. Lancien, V. L. Tran, M. Susset, B. Jego, F. Theodoro, P. Kessler, G. Mourier, P. Robin, S. S. Diarra, S. Palea, A. Flahault, A. Chorfa, M. Corbani, C. Llorens-Cortes, B. Mouillac, C. Mendre, A. Pruvost, D. Servent, C. Truillet, N. Gilles. A snake toxin as a theranostic agent for the type 2 vasopressin receptor

    Theranostics, vol. 10, 2020, pp. 11580-11594
    

72. F. E. Escorcia, J. L. Houghton, D. Abdel-Atti, P. R. Pereira, A. Cho, N. T. Gutsche, K. E. Baidoo, J. S. Lewis. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors

    Theranostics, vol. 10, 2020, pp. 151-165
    

73. X. Feng, Y. Wang, D. Lu, X. Xu, X. Zhou, H. Zhang, T. Zhang, H. Zhu, Z. Yang, F. Wang, N. Li, Z. Liu. Clinical Translation of a ⁶⁸Ga-Labeled Integrin α v β 6-Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer

    J Nucl Med, vol. 61, 2020, pp. 1461-1467
    

74. T. M. Fenton, P. B. Jørgensen, K. Niss, S. J. S. Rubin, U. M. Mörbe, L. B. Riis, C. Da Silva, A. Plumb, J. Vandamme, H. L. Jakobsen, S. Brunak, A. Habtezion, O. H. Nielsen, B. Johansson-Lindbom, W. W. Agace. Immune Profiling of Human Gut-Associated Lymphoid Tissue Identifies a Role for Isolated Lymphoid Follicles in Priming of Region-Specific Immunity

    Immunity, vol. 52, 2020, pp. 557-570.e6
    

75. Gfds Fernandes, H. R. N. Salgado, J. L. D. Santos. A critical review of HPLC-based analytical methods for quantification of Linezolid

    Crit Rev Anal Chem, vol. 50, 2020, pp. 196-211
    

76. E. Friebel, K. Kapolou, S. Unger, N. G. Núñez, S. Utz, E. J. Rushing, L. Regli, M. Weller, M. Greter, S. Tugues, M. C. Neidert, B. Becher. Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes

    Cell, vol. 181, 2020, pp. 1626-1642.e20
    

77. Jacm Goos, A. Cho, L. M. Carter, T. R. Dilling, M. Davydova, K. Mandleywala, S. Puttick, A. Gupta, W. S. Price, J. F. Quinn, M. R. Whittaker, J. S. Lewis, T. P. Davis. Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect

    Theranostics, vol. 10, 2020, pp. 567-584
    

78. J. R. Henriksen, T. B. Engel, A. L. Petersen, P. J. Kempen, F. Melander, P. Roos, R. I. Jølck, T. L. Andresen. Elucidating the anomalous membrane permeability of Ag(I), Cu(II), Zn(II) and Au(III) towards new nanoreactor strategies for synthesizing metal nanoparticles

    Nanoscale, vol. 12, 2020, pp. 22298-22306
    

79. S. Hossaini Nasr, Z. Rashidijahanabad, S. Ramadan, N. Kauffman, N. Parameswaran, K. R. Zinn, C. Qian, R. Arora, D. Agnew, X. Huang. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles

    Nanoscale, vol. 12, 2020, pp. 9541-9556
    

80. R. Houštecká, M. Hadzima, J. Fanfrlík, J. Brynda, L. Pallová, I. Hánová, H. Mertlíková-Kaiserová, M. Lepšík, M. Horn, M. Smrčina, P. Majer, M. Mareš. Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure-Activity Relationship and Binding Mode Analysis

    J Med Chem, vol. 63, 2020, pp. 1576-1596
    

81. C. W. Huang, Y. H. Chang, H. H. Lee, J. Y. Wu, J. X. Huang, Y. H. Chung, S. T. Hsu, L. P. Chow, K. C. Wei, F. T. Huang. Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma

    Faseb j, vol. 34, 2020, pp. 9678-9693
    

82. A. Karimian, N. T. Ji, H. Song, G. Sgouros. Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy

    Cancer Res, vol. 80, 2020, pp. 868-876
    

83. V. J. Kelly, S. T. Wu, V. Gottumukkala, R. Coelho, K. Palmer, S. Nair, T. Erick, R. Puri, O. Ilovich, P. Mukherjee. Preclinical evaluation of an (111)In/(225)Ac theranostic targeting transformed MUC1 for triple negative breast cancer

    Theranostics, vol. 10, 2020, pp. 6946-6958
    

84. A. Kolstad, T. Illidge, N. Bolstad, S. Spetalen, U. Madsbu, C. Stokke, J. Blakkisrud, A. Løndalen, N. O\'Rourke, M. Beasley, W. Jurczak, U. M. Fagerli, M. Kaščák, M. Bayne, A. Obr, J. Dahle, L. Rojkjaer, V. Pascal, H. Holte. Phase 1/2a study of ¹⁷⁷Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

    Blood Adv, vol. 4, 2020, pp. 4091-4101
    

85. K. E. Lindsay, D. Vanover, M. Thoresen, H. King, P. Xiao, P. Badial, M. Araínga, S. B. Park, P. M. Tiwari, H. E. Peck, E. L. Blanchard, J. M. Feugang, A. K. Olivier, C. Zurla, F. Villinger, A. R. Woolums, P. J. Santangelo. Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV

    Mol Ther, vol. 28, 2020, pp. 805-819
    

86. D. Lobeek, M. Rijpkema, S. Y. A. Terry, J. D. M. Molkenboer-Kuenen, L. Joosten, E. A. J. van Genugten, A. C. H. van Engen-van Grunsven, Jham Kaanders, S. A. H. Pegge, O. C. Boerman, W. L. J. Weijs, M. A. W. Merkx, C. M. L. van Herpen, R. P. Takes, Ehjg Aarntzen, W. J. G. Oyen. Imaging angiogenesis in patients with head and neck squamous cell carcinomas by ⁶⁸Ga-DOTA-E-[c(RGDfK)] 2 PET/CT

    Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 2647-2655
    

87. G. Lv, X. Sun, L. Qiu, Y. Sun, K. Li, Q. Liu, Q. Zhao, S. Qin, J. Lin. PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody

    J Nucl Med, vol. 61, 2020, pp. 117-122
    

88. N. Nair, S. Y. Chen, E. Lemmens, S. Chang, D. T. Le, E. M. Jaffee, A. Murphy, C. Whiting, T. Müller, D. G. Brockstedt. Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer

    Cancer Immunol Res, vol. 8, 2020, pp. 609-617
    

89. T. D. T. Nguyen, R. Marasini, S. Rayamajhi, C. Aparicio, D. Biller, S. Aryal. Erythrocyte membrane concealed paramagnetic polymeric nanoparticle for contrast-enhanced magnetic resonance imaging

    Nanoscale, vol. 12, 2020, pp. 4137-4149
    

90. Y. C. Ou, X. Wen, C. A. Johnson, D. Shae, O. D. Ayala, J. A. Webb, E. C. Lin, R. C. DeLapp, K. L. Boyd, A. Richmond, A. Mahadevan-Jansen, M. Rafat, J. T. Wilson, J. M. Balko, M. N. Tantawy, A. E. Vilgelm, R. Bardhan. Multimodal Multiplexed Immunoimaging with Nanostars to Detect Multiple Immunomarkers and Monitor Response to Immunotherapies

    ACS Nano, vol. 14, 2020, pp. 651-663
    

91. N. Pandit-Taskar, M. A. Postow, M. D. Hellmann, J. J. Harding, C. A. Barker, J. A. O\'Donoghue, M. Ziolkowska, S. Ruan, S. K. Lyashchenko, F. Tsai, M. Farwell, T. C. Mitchell, R. Korn, W. Le, J. S. Lewis, W. A. Weber, D. Behera, I. Wilson, M. Gordon, A. M. Wu, J. D. Wolchok. First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting

    J Nucl Med, vol. 61, 2020, pp. 512-519
    

92. E. Peplau, F. De Rose, S. Reder, M. Mittelhäuser, G. Scafetta, M. Schwaiger, W. A. Weber, A. Bartolazzi, A. Skerra, C. D\'Alessandria. Development of a Chimeric Antigen-Binding Fragment Directed Against Human Galectin-3 and Validation as an Immuno-Positron Emission Tomography Tracer for the Sensitive In Vivo Imaging of Thyroid Cancer

    Thyroid, vol. 30, 2020, pp. 1314-1326
    

93. P. M. R. Pereira, K. Mandleywala, A. Ragupathi, J. S. Lewis. Acute Statin Treatment Improves Antibody Accumulation in EGFR- and PSMA-Expressing Tumors

    Clin Cancer Res, vol. 26, 2020, pp. 6215-6229
    

94. A. Pichard, S. Marcatili, J. Karam, J. Constanzo, R. Ladjohounlou, A. Courteau, M. Jarlier, N. Bonnefoy, S. Patzke, V. Stenberg, P. Coopman, G. Cartron, I. Navarro-Teulon, A. Repetto-Llamazares, H. Heyerdahl, J. Dahle, M. Bardiès, J. P. Pouget. The therapeutic effectiveness of ¹⁷⁷Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest

    Leukemia, vol. 34, 2020, pp. 1315-1328
    

95. X. Qin, J. Sufi, P. Vlckova, P. Kyriakidou, S. E. Acton, V. S. W. Li, M. Nitz, C. J. Tape. Cell-type-specific signaling networks in heterocellular organoids

    Nat Methods, vol. 17, 2020, pp. 335-342
    

96. I. Quelven, J. Monteil, M. Sage, A. Saidi, J. Mounier, A. Bayout, J. Garrier, M. Cogne, S. Durand-Panteix. ²¹²Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study

    J Nucl Med, vol. 61, 2020, pp. 1058-1065
    

97. S. Rayamajhi, R. Marasini, T. D. T. Nguyen, B. L. Plattner, D. Biller, S. Aryal. Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent

    Biomater Sci, vol. 8, 2020, pp. 2887-2904
    

98. E. K. Sarbisheh, A. K. Salih, S. J. Raheem, J. S. Lewis, E. W. Price. A High-Denticity Chelator Based on Desferrioxamine for Enhanced Coordination of Zirconium-89

    Inorg Chem, vol. 59, 2020, pp. 11715-11727
    

99. L. J. Savic, L. A. Doemel, I. T. Schobert, R. R. Montgomery, N. Joshi, J. J. Walsh, J. Santana, V. Pekurovsky, X. Zhang, M. Lin, L. Adam, A. Boustani, J. Duncan, L. Leng, R. J. Bucala, S. N. Goldberg, F. Hyder, D. Coman, J. Chapiro. Molecular MRI of the Immuno-Metabolic Interplay in a Rabbit Liver Tumor Model: A Biomarker for Resistance Mechanisms in Tumor-targeted Therapy?

    Radiology, vol. 296, 2020, pp. 575-583
    

100. L. J. Savic, I. T. Schobert, D. Peters, J. J. Walsh, F. M. Laage-Gaupp, C. A. Hamm, N. Tritz, L. A. Doemel, M. Lin, A. Sinusas, T. Schlachter, J. S. Duncan, F. Hyder, D. Coman, J. Chapiro. Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment

     Clin Cancer Res, vol. 26, 2020, pp. 428-438
     

101. M. L. Senders, A. E. Meerwaldt, M. M. T. van Leent, B. L. Sanchez-Gaytan, J. C. van de Voort, Y. C. Toner, A. Maier, E. D. Klein, N. A. T. Sullivan, A. M. Sofias, H. Groenen, C. Faries, R. S. Oosterwijk, E. M. van Leeuwen, F. Fay, E. Chepurko, T. Reiner, R. Duivenvoorden, L. Zangi, R. M. Dijkhuizen, S. Hak. Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging

     Nat Nanotechnol, vol. 15, 2020, pp. 398-405
     

102. B. Shi, B. Zhang, Y. Zhang, Y. Gu, C. Zheng, J. Yan, W. Chen, F. Yan, J. Ye, H. Zhang. Multifunctional gap-enhanced Raman tags for preoperative and intraoperative cancer imaging

     Acta Biomater, vol. 104, 2020, pp. 210-220
     

103. S. Slight-Webb, M. Smith, A. Bylinska, S. Macwana, C. Guthridge, R. Lu, J. T. Merrill, E. Chakravarty, C. Arriens, M. E. Munroe, H. T. Maecker, P. J. Utz, J. M. Guthridge, J. A. James. Autoantibody-positive healthy individuals with lower lupus risk display a unique immune endotype

     J Allergy Clin Immunol, vol. 146, 2020, pp. 1419-1433
     

104. R. Tang, A. Zheleznyak, M. Mixdorf, A. Ghai, J. Prior, K. C. L. Black, M. Shokeen, N. Reed, P. Biswas, S. Achilefu. Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma

     ACS Nano, vol. 14, 2020, pp. 4255-4264
     

105. L. Tortola, A. Jacobs, L. Pohlmeier, F. J. Obermair, F. Ampenberger, B. Bodenmiller, M. Kopf. High-Dimensional T Helper Cell Profiling Reveals a Broad Diversity of Stably Committed Effector States and Uncovers Interlineage Relationships

     Immunity, vol. 53, 2020, pp. 597-613.e6
     

106. G. A. Ulaner, N. B. Sobol, J. A. O'Donoghue, A. S. Kirov, C. C. Riedl, R. Min, E. Smith, L. M. Carter, S. K. Lyashchenko, J. S. Lewis, C. O. Landgren. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging

     Radiology, vol. 295, 2020, pp. 606-615
     

107. T. J. van Oostenbrugge, J. F. Langenhuijsen, E. Oosterwijk, O. C. Boerman, S. F. Jenniskens, W. J. G. Oyen, J. J. Fütterer, P. F. A. Mulders. Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab

     Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 1864-1870
     

108. B. A. Vaughn, A. M. Brown, S. H. Ahn, J. R. Robinson, E. Boros. Is Less More? Influence of the Coordination Geometry of Copper(II) Picolinate Chelate Complexes on Metabolic Stability

     Inorg Chem, vol. 59, 2020, pp. 16095-16108
     

109. Y. Wang, C. Zhang, J. Lai, Y. Zhao, D. Lu, R. Bao, X. Feng, T. Zhang, Z. Liu. Noninvasive PET tracking of post-transplant gut microbiota in living mice

     Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 991-1002
     

110. W. Wei, D. Jiang, H. J. Lee, M. Li, C. J. Kutyreff, J. W. Engle, J. Liu, W. Cai. Development and characterization of CD54-targeted immunoPET imaging in solid tumors

     Eur J Nucl Med Mol Imaging, vol. 47, 2020, pp. 2765-2775
     

111. A. W. Woodham, S. H. Zeigler, E. L. Zeyang, S. C. Kolifrath, R. W. Cheloha, M. Rashidian, R. J. Chaparro, R. D. Seidel, S. J. Garforth, J. L. Dearling, M. Mesyngier, P. K. Duddempudi, A. B. Packard, S. C. Almo, H. L. Ploegh. In vivo detection of antigen-specific CD8(+) T cells by immuno-positron emission tomography

     Nat Methods, vol. 17, 2020, pp. 1025-1032
     

112. Z. Xiao, A. T. Mayer, T. W. Nobashi, S. S. Gambhir. ICOS Is an Indicator of T-cell-Mediated Response to Cancer Immunotherapy

     Cancer Res, vol. 80, 2020, pp. 3023-3032
     

113. C. Xu, H. Hong, Y. Lee, K. S. Park, M. Sun, T. Wang, M. E. Aikins, Y. Xu, J. J. Moon. Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets

     ACS Nano, vol. 14, 2020, pp. 13268-13278
     

114. A. C. Yang, M. Y. Stevens, M. B. Chen, D. P. Lee, D. Stähli, D. Gate, K. Contrepois, W. Chen, T. Iram, L. Zhang, R. T. Vest, A. Chaney, B. Lehallier, N. Olsson, H. du Bois, R. Hsieh, H. C. Cropper, D. Berdnik, L. Li, E. Y. Wang, G. M. Traber. Physiological blood-brain transport is impaired with age by a shift in transcytosis

     Nature, vol. 583, 2020, pp. 425-430
     

115. H. Zhu, T. L. Liu, C. H. Liu, J. Wang, H. Zhang, B. Dong, J. Shen, C. K. Zhao, Z. F. Li, Z. Cheng, Z. Yang. Evaluation of a novel monoclonal antibody mAb109 by immuno-PET/fluorescent imaging for noninvasive lung adenocarcinoma diagnosis

     Acta Pharmacol Sin, vol. 41, 2020, pp. 101-109
     

2019

116. S. R. Banerjee, V. Kumar, A. Lisok, D. Plyku, Z. Nováková, M. Brummet, B. Wharram, C. Barinka, R. Hobbs, M. G. Pomper. Evaluation of ¹¹¹In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen

     J Nucl Med, vol. 60, 2019, pp. 400-406
     

117. N. Beziere, K. Fuchs, A. Maurer, G. Reischl, J. Brück, K. Ghoreschi, B. Fehrenbacher, D. C. Berrio, K. Schenke-Layland, U. Kohlhofer, L. Quintanilla-Martinez, M. Gawaz, M. Kneilling, B. Pichler. Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix

     Theranostics, vol. 9, 2019, pp. 2868-2881
     

118. D. V. Bower, J. K. Richter, H. von Tengg-Kobligk, J. T. Heverhagen, V. M. Runge. Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent

     Invest Radiol, vol. 54, 2019, pp. 453-463
     

119. J. Boyken, T. Frenzel, J. Lohrke, G. Jost, G. Schütz, H. Pietsch. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats

     Invest Radiol, vol. 54, 2019, pp. 76-82
     

120. C. Buchwalder, M. G. Jaraquemada-Peláez, J. Rousseau, H. Merkens, C. Rodríguez-Rodríguez, C. Orvig, F. Bénard, P. Schaffer, K. Saatchi, U. O. Häfeli. Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular ⁸⁹Zr-THPN-Conjugates

     Inorg Chem, vol. 58, 2019, pp. 14667-14681
     

121. L. Budzinski, A. R. Schulz, S. Baumgart, T. Burns, T. Rose, H. Hirseland, H. E. Mei. Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry

     J Immunol, vol. 202, 2019, pp. 3103-3112
     

122. E. R. Butch, P. E. Mead, V. Amador Diaz, H. Tillman, E. Stewart, J. K. Mishra, J. Kim, A. Bahrami, J. L. J. Dearling, A. B. Packard, S. V. Stoddard, A. L. Vāvere, Y. Han, B. L. Shulkin, S. E. Snyder. Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma

     Cancer Res, vol. 79, 2019, pp. 3112-3124
     

123. Q. Cao, Q. Huang, C. Mohan, C. Li. Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using ⁶⁴Cu-αCD11b

     J Nucl Med, vol. 60, 2019, pp. 1317-1324
     

124. D. Chen, Y. Zhou, D. Yang, M. Guan, M. Zhen, W. Lu, M. E. Van Dort, B. D. Ross, C. Wang, C. Shu, H. Hong. Positron Emission Tomography/Magnetic Resonance Imaging of Glioblastoma Using a Functionalized Gadofullerene Nanoparticle

     ACS Appl Mater Interfaces, vol. 11, 2019, pp. 21343-21352
     

125. N. Dmochowska, W. Tieu, M. D. Keller, H. R. Wardill, C. Mavrangelos, M. A. Campaniello, P. Takhar, P. A. Hughes. Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis

     J Nucl Med, vol. 60, 2019, pp. 858-863
     

126. C. A. Dutertre, E. Becht, S. E. Irac, A. Khalilnezhad, V. Narang, S. Khalilnezhad, P. Y. Ng, L. L. van den Hoogen, J. Y. Leong, B. Lee, M. Chevrier, X. M. Zhang, P. J. A. Yong, G. Koh, J. Lum, S. W. Howland, E. Mok, J. Chen, A. Larbi, H. K. K. Tan, T. K. H. Lim, P. Karagianni, A. G. Tzioufas, B. Malleret, J. Brody, S. Albani, J. van Roon, T. Radstake, E. W. Newell, F. Ginhoux. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells

     Immunity, vol. 51, 2019, pp. 573-589.e8
     

127. W. Fan, W. Zhang, S. Alshehri, T. R. Neeley, J. C. Garrison. Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor

     Eur J Med Chem, vol. 177, 2019, pp. 386-400
     

128. Q. Fu, A. Piai, W. Chen, K. Xia, J. J. Chou. Structure determination protocol for transmembrane domain oligomers

     Nat Protoc, vol. 14, 2019, pp. 2483-2520
     

129. J. Garousi, S. Lindbo, J. Borin, E. von Witting, A. Vorobyeva, M. Oroujeni, B. Mitran, A. Orlova, J. Buijs, V. Tolmachev, S. Hober. Comparative evaluation of dimeric and monomeric forms of ADAPT scaffold protein for targeting of HER2-expressing tumours

     Eur J Pharm Biopharm, vol. 134, 2019, pp. 37-48
     

130. K. E. Henry, M. M. Dacek, T. R. Dilling, J. D. Caen, I. L. Fox, M. J. Evans, J. S. Lewis. A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer

     Clin Cancer Res, vol. 25, 2019, pp. 166-176
     

131. S. Heskamp, P. J. Wierstra, J. D. M. Molkenboer-Kuenen, G. W. Sandker, S. Thordardottir, J. Cany, D. Olive, J. Bussink, O. C. Boerman, H. Dolstra, Ehjg Aarntzen, W. A. Hobo. PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

     Cancer Immunol Res, vol. 7, 2019, pp. 150-161
     

132. S. H. L. Hoffmann, D. I. Reck, A. Maurer, B. Fehrenbacher, J. E. Sceneay, M. Poxleitner, H. H. Öz, W. Ehrlichmann, G. Reischl, K. Fuchs, M. Schaller, D. Hartl, M. Kneilling, A. Möller, B. J. Pichler, C. M. Griessinger. Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer

     Theranostics, vol. 9, 2019, pp. 5869-5885
     

133. S. Imlimthan, S. Otaru, O. Keinänen, A. Correia, K. Lintinen, H. A. Santos, A. J. Airaksinen, M. A. Kostiainen, M. Sarparanta. Radiolabeled Molecular Imaging Probes for the In Vivo Evaluation of Cellulose Nanocrystals for Biomedical Applications

     Biomacromolecules, vol. 20, 2019, pp. 674-683
     

134. N. Jailkhani, J. R. Ingram, M. Rashidian, S. Rickelt, C. Tian, H. Mak, Z. Jiang, H. L. Ploegh, R. O. Hynes. Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix

     Proc Natl Acad Sci U S A, vol. 116, 2019, pp. 14181-14190
     

135. L. K. Kristensen, C. Christensen, M. M. Jensen, B. J. Agnew, C. Schjöth-Frydendahl, A. Kjaer, C. H. Nielsen. Site-specifically labeled ⁸⁹Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model

     Theranostics, vol. 9, 2019, pp. 4409-4420
     

136. L. K. Kristensen, C. Fröhlich, C. Christensen, M. C. Melander, T. T. Poulsen, G. R. Galler, J. Lantto, I. D. Horak, M. Kragh, C. H. Nielsen, A. Kjaer. CD4(+) and CD8a(+) PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models

     Theranostics, vol. 9, 2019, pp. 8221-8238
     

137. R. Ladjohounlou, C. Lozza, A. Pichard, J. Constanzo, J. Karam, P. Le Fur, E. Deshayes, V. Boudousq, S. Paillas, M. Busson, M. Le Blay, M. Jarlier, S. Marcatili, M. Bardiès, F. Bruchertseifer, A. Morgenstern, J. Torgue, I. Navarro-Teulon, J. P. Pouget. Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy

     Clin Cancer Res, vol. 25, 2019, pp. 4775-4790
     

138. H. J. Lee, E. B. Ehlerding, D. Jiang, T. E. Barnhart, T. Cao, W. Wei, C. A. Ferreira, P. Huang, J. W. Engle, W. Cai. Dual-labeled pertuzumab for multimodality image-guided ovarian tumor resection

     Am J Cancer Res, vol. 9, 2019, pp. 1454-1468
     

139. W. G. Lesniak, C. Chu, A. Jablonska, B. Behnam Azad, O. Zwaenepoel, M. Zawadzki, A. Lisok, M. G. Pomper, P. Walczak, J. Gettemans, M. Janowski. PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration

     Eur J Nucl Med Mol Imaging, vol. 46, 2019, pp. 1940-1951
     

140. W. G. Lesniak, C. Chu, A. Jablonska, Y. Du, M. G. Pomper, P. Walczak, M. Janowski. A Distinct Advantage to Intraarterial Delivery of ⁸⁹Zr-Bevacizumab in PET Imaging of Mice With and Without Osmotic Opening of the Blood-Brain Barrier

     J Nucl Med, vol. 60, 2019, pp. 617-622
     

141. M. Li, D. Jiang, T. E. Barnhart, T. Cao, J. W. Engle, W. Chen, W. Cai. Immuno-PET imaging of VEGFR-2 expression in prostate cancer with ⁸⁹Zr-labeled ramucirumab

     Am J Cancer Res, vol. 9, 2019, pp. 2037-2046
     

142. Y. Liang, Q. Liu, Y. Zhou, S. Chen, L. Yang, M. Zhu, Q. Wang. Counting and Recognizing Single Bacterial Cells by a Lanthanide-Encoding Inductively Coupled Plasma Mass Spectrometric Approach

     Anal Chem, vol. 91, 2019, pp. 8341-8349
     

143. A. Y. Liu, A. D. Kanan, T. P. Radon, S. Shah, M. E. Weeks, J. M. Foster, J. K. Sosabowski, L. Dumartin, T. Crnogorac-Jurcevic. AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting

     Oncotarget, vol. 10, 2019, pp. 4276-4289
     

144. Q. Liu, E. M. Johnson, R. K. Lam, Q. Wang, H. Bo Ye, E. N. Wilson, P. S. Minhas, L. Liu, M. S. Swarovski, S. Tran, J. Wang, S. S. Mehta, X. Yang, J. D. Rabinowitz, S. S. Yang, M. Shamloo, C. Mueller, M. L. James, K. I. Andreasson. Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity

     Nat Immunol, vol. 20, 2019, pp. 1023-1034
     

145. Y. Liu, H. P. Luehmann, L. Detering, E. D. Pressly, A. J. McGrath, D. Sultan, A. Nguyen, S. Grathwohl, M. Shokeen, M. Zayed, R. J. Gropler, D. Abendschein, C. J. Hawker, P. K. Woodard. Assessment of Targeted Nanoparticle Assemblies for Atherosclerosis Imaging with Positron Emission Tomography and Potential for Clinical Translation

     ACS Appl Mater Interfaces, vol. 11, 2019, pp. 15316-15321
     

146. C. Lohrmann, E. M. O'Reilly, J. A. O'Donoghue, N. Pandit-Taskar, J. A. Carrasquillo, S. K. Lyashchenko, S. Ruan, R. Teng, W. Scholz, P. W. Maffuid, J. S. Lewis, W. A. Weber. Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

     Clin Cancer Res, vol. 25, 2019, pp. 7014-7023
     

147. X. K. Lun, D. Szklarczyk, A. Gabor, N. Dobberstein, V. R. T. Zanotelli, J. Saez-Rodriguez, C. von Mering, B. Bodenmiller. Analysis of the Human Kinome and Phosphatome by Mass Cytometry Reveals Overexpression-Induced Effects on Cancer-Related Signaling

     Mol Cell, vol. 74, 2019, pp. 1086-1102.e5
     

148. S. Lütje, S. Heskamp, G. M. Franssen, C. Frielink, A. Kip, M. Hekman, G. Fracasso, M. Colombatti, K. Herrmann, O. C. Boerman, M. Gotthardt, M. Rijpkema. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors

     Theranostics, vol. 9, 2019, pp. 2924-2938
     

149. A. F. Maaland, H. Heyerdahl, A. O'Shea, B. Eiriksdottir, V. Pascal, J. T. Andersen, A. Kolstad, J. Dahle. Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate (177)Lu-NNV003

     Eur J Nucl Med Mol Imaging, vol. 46, 2019, pp. 2311-2321
     

150. O. A. Marcos-Contreras, J. S. Brenner, R. Y. Kiseleva, V. Zuluaga-Ramirez, C. F. Greineder, C. H. Villa, E. D. Hood, J. W. Myerson, S. Muro, Y. Persidsky, V. R. Muzykantov. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain

     J Control Release, vol. 301, 2019, pp. 54-61
     

151. H. Mukai, K. Hatanaka, N. Yagi, S. Warashina, M. Zouda, M. Takahashi, K. Narushima, H. Yabuuchi, J. Iwano, T. Kuboyama, J. Enokizono, Y. Wada, Y. Watanabe. Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis

     J Control Release, vol. 294, 2019, pp. 185-194
     

152. A. Natarajan, C. B. Patel, S. Ramakrishnan, P. S. Panesar, S. R. Long, S. S. Gambhir. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues

     Clin Cancer Res, vol. 25, 2019, pp. 1774-1785
     

153. A. C. L. Opina, M. Strickland, Y. S. Lee, N. Tjandra, R. E. Swenson, O. Vasalatiy. Comparison of Solution Properties of Polymethylated DOTA-like Lanthanide Complexes with Opposite Chirality of the Pendant Arms

     Inorg Chem, vol. 58, 2019, pp. 15788-15800
     

154. L. Pan, T. M. Fu, W. Zhao, L. Zhao, W. Chen, C. Qiu, W. Liu, Z. Liu, A. Piai, Q. Fu, S. Chen, H. Wu, J. J. Chou. Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling

     Cell, vol. 176, 2019, pp. 1477-1489.e14
     

155. D. N. Pandya, N. B. Bhatt, F. Almaguel, S. Rideout-Danner, H. D. Gage, K. K. Solingapuram Sai, T. J. Wadas. ⁸⁹Zr-Chloride Can Be Used for Immuno-PET Radiochemistry Without Loss of Antigen Reactivity In Vivo

     J Nucl Med, vol. 60, 2019, pp. 696-701
     

156. H. H. Pang, P. Y. Chen, K. C. Wei, C. W. Huang, Y. L. Shiue, C. Y. Huang, H. W. Yang. Convection-Enhanced Delivery of a Virus-Like Nanotherapeutic Agent with Dual-Modal Imaging for Besiegement and Eradication of Brain Tumors

     Theranostics, vol. 9, 2019, pp. 1752-1763
     

157. P. M. R. Pereira, K. Mandleywala, A. Ragupathi, L. M. Carter, Jacm Goos, Y. Y. Janjigian, J. S. Lewis. Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors

     J Nucl Med, vol. 60, 2019, pp. 1569-1578
     

158. J. Riegler, H. Gill, A. Ogasawara, M. Hedehus, V. Javinal, J. Oeh, G. Z. Ferl, J. Marik, S. Williams, D. Sampath, J. Schartner, R. A. D. Carano. VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models

     Neoplasia, vol. 21, 2019, pp. 1036-1050
     

159. D. R. Roberts, A. R. Chatterjee. The Critical Need for Pediatric and Juvenile Animal Research Addressing Gadolinium Retention in the Developing Body

     Invest Radiol, vol. 54, 2019, pp. 72-75
     

160. E. Sanabria Español, M. Maldonado. Host-Guest Recognition of Pesticides by Calixarenes

     Crit Rev Anal Chem, vol. 49, 2019, pp. 383-394
     

161. N. Schaduangrat, V. Prachayasittikul, S. Choomwattana, P. Wongchitrat, K. Phopin, W. Suwanjang, A. A. Malik, B. Vincent, C. Nantasenamat. Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease

     Med Res Rev, vol. 39, 2019, pp. 1730-1778
     

162. I. H. Song, M. S. Jeong, H. J. Hong, J. I. Shin, Y. S. Park, S. K. Woo, B. S. Moon, K. I. Kim, Y. J. Lee, J. H. Kang, T. S. Lee. Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma Model

     Clin Cancer Res, vol. 25, 2019, pp. 6148-6159
     

163. S. M. Srideshikan, J. Brooks, D. Zuro, B. Kumar, J. Sanchez, L. Echavarria Parra, M. Orellana, P. Vishwasrao, I. Nair, J. Chea, K. Poku, N. Bowles, A. Miller, T. Ebner, J. Molnar, J. Rosenthal, D. A. Vallera, J. Y. C. Wong, A. S. Stein, D. Colcher, J. E. Shively. ImmunoPET, ⁶⁴Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model

     Clin Cancer Res, vol. 25, 2019, pp. 7463-7474
     

164. T. A. R. Stallons, A. Saidi, I. Tworowska, E. S. Delpassand, J. J. Torgue, A. H. Staudacher, V. Liapis, W. Tieu, N. L. Wittwer, M. P. Brown. Preclinical Investigation of ²¹²Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model

     Mol Cancer Ther, vol. 18, 2019, pp. 1012-1021
     

165. B. W. Stein, A. Morgenstern, E. R. Batista, E. R. Birnbaum, S. E. Bone, S. K. Cary, M. G. Ferrier, K. D. John, J. L. Pacheco, S. A. Kozimor, V. Mocko, B. L. Scott, P. Yang. Advancing Chelation Chemistry for Actinium and Other +3 f-Elements, Am, Cm, and La

     J Am Chem Soc, vol. 141, 2019, pp. 19404-19414
     

166. H. Sudo, A. B. Tsuji, A. Sugyo, T. Saga, M. K. Kaneko, Y. Kato, T. Higashi. Therapeutic efficacy evaluation of radioimmunotherapy with (90) Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma

     Cancer Sci, vol. 110, 2019, pp. 1653-1664
     

167. D. L. J. Thorek, A. T. Ku, N. Mitsiades, D. Veach, P. A. Watson, D. Metha, S. E. Strand, S. K. Sharma, J. S. Lewis, D. S. Abou, H. G. Lilja, S. M. Larson, M. R. McDevitt, D. Ulmert. Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer

     Clin Cancer Res, vol. 25, 2019, pp. 881-891
     

168. O. V. Timmermand, J. Elgqvist, K. A. Beattie, A. Örbom, E. Larsson, S. E. Eriksson, D. L. J. Thorek, B. J. Beattie, T. A. Tran, D. Ulmert, S. E. Strand. Preclinical efficacy of hK2 targeted [¹⁷⁷Lu]hu11B6 for prostate cancer theranostics

     Theranostics, vol. 9, 2019, pp. 2129-2142
     

169. J. Wagner, M. A. Rapsomaniki, S. Chevrier, T. Anzeneder, C. Langwieder, A. Dykgers, M. Rees, A. Ramaswamy, S. Muenst, S. D. Soysal, A. Jacobs, J. Windhager, K. Silina, M. van den Broek, K. J. Dedes, M. Rodríguez Martínez, W. P. Weber, B. Bodenmiller. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer

     Cell, vol. 177, 2019, pp. 1330-1345.e18
     

170. W. Wei, D. Jiang, Z. T. Rosenkrans, T. E. Barnhart, J. W. Engle, Q. Luo, W. Cai. HER2-targeted multimodal imaging of anaplastic thyroid cancer

     Am J Cancer Res, vol. 9, 2019, pp. 2413-2427
     

171. S. K. Woo, S. J. Jang, M. J. Seo, J. H. Park, B. S. Kim, E. J. Kim, Y. J. Lee, T. S. Lee, G. I. An, I. H. Song, Y. Seo, K. I. Kim, J. H. Kang. Development of ⁶⁴Cu-NOTA-Trastuzumab for HER2 Targeting: A Radiopharmaceutical with Improved Pharmacokinetics for Human Studies

     J Nucl Med, vol. 60, 2019, pp. 26-33
     

172. X. Xie, Y. Chen, Z. Chen, Y. Feng, J. Wang, T. Li, S. Li, X. Qin, C. Wu, C. Zheng, J. Zhu, F. You, Y. Liu, H. Yang. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging

     ACS Appl Mater Interfaces, vol. 11, 2019, pp. 43865-43878
     

173. C. Xu, J. Nam, H. Hong, Y. Xu, J. J. Moon. Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy

     ACS Nano, vol. 13, 2019, pp. 12148-12161
     

174. H. Yakushiji, K. Kobayashi, F. Takenaka, Y. Kishi, M. Shinohara, M. Akehi, T. Sasaki, E. Ohno, E. Matsuura. Novel single-chain variant of antibody against mesothelin established by phage library

     Cancer Sci, vol. 110, 2019, pp. 2722-2733
     

175. Z. Yang, Y. Dai, L. Shan, Z. Shen, Z. Wang, B. C. Yung, O. Jacobson, Y. Liu, W. Tang, S. Wang, L. Lin, G. Niu, P. Huang, X. Chen. Tumour microenvironment-responsive semiconducting polymer-based self-assembly nanotheranostics

     Nanoscale Horiz, vol. 4, 2019, pp. 426-433
     

2018

176. I. S. Alam, A. T. Mayer, I. Sagiv-Barfi, K. Wang, O. Vermesh, D. K. Czerwinski, E. M. Johnson, M. L. James, R. Levy, S. S. Gambhir. Imaging activated T cells predicts response to cancer vaccines

     J Clin Invest, vol. 128, 2018, pp. 2569-2580
     

177. M. E. Autenrieth, C. Seidl, F. Bruchertseifer, T. Horn, F. Kurtz, B. Feuerecker, C. D'Alessandria, C. Pfob, S. Nekolla, C. Apostolidis, S. Mirzadeh, J. E. Gschwend, M. Schwaiger, K. Scheidhauer, A. Morgenstern. Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study

     Eur J Nucl Med Mol Imaging, vol. 45, 2018, pp. 1364-1371
     

178. S. R. Banerjee, X. Song, X. Yang, I. Minn, A. Lisok, Y. Chen, A. Bui, S. Chatterjee, J. Chen, P. C. M. van Zijl, M. T. McMahon, M. G. Pomper. Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer

     Chemistry, vol. 24, 2018, pp. 7235-7242
     

179. I. J. G. Burvenich, S. Parakh, F. T. Lee, N. Guo, Z. Liu, H. K. Gan, A. Rigopoulos, G. J. O\'Keefe, S. J. Gong, Y. W. Goh, H. Tochon-Danguy, F. E. Scott, M. Kotsuma, K. Hirotani, G. Senaldi, A. M. Scott. Molecular imaging of T cell co-regulator factor B7-H3 with ⁸⁹Zr-DS-5573a

     Theranostics, vol. 8, 2018, pp. 4199-4209
     

180. M. N. Centelles, M. Wright, P. W. So, M. Amrahli, X. Y. Xu, J. Stebbing, A. D. Miller, W. Gedroyc, M. Thanou. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours

     J Control Release, vol. 280, 2018, pp. 87-98
     

181. R. Chekol, V. R. Solomon, E. Alizadeh, W. Bernhard, D. Fisher, W. Hill, K. Barreto, J. F. DeCoteau, A. C. Parada, C. R. Geyer, H. Fonge. ⁸⁹Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I

     Oncotarget, vol. 9, 2018, pp. 17117-17132
     

182. W. Chen, J. Dev, J. Mezhyrova, L. Pan, A. Piai, J. J. Chou. The Unusual Transmembrane Partition of the Hexameric Channel of the Hepatitis C Virus

     Structure, vol. 26, 2018, pp. 627-634.e4
     

183. C. C. Cheng, K. F. Chou, C. W. Wu, N. W. Su, C. L. Peng, Y. W. Su, J. Chang, A. S. Ho, H. C. Lin, C. G. Chen, B. L. Yang, Y. C. Chang, Y. W. Chiang, K. H. Lim, Y. F. Chang. EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer

     Lung Cancer, vol. 116, 2018, pp. 80-89
     

184. S. Chevrier, H. L. Crowell, V. R. T. Zanotelli, S. Engler, M. D. Robinson, B. Bodenmiller. Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry

     Cell Syst, vol. 6, 2018, pp. 612-620.e5
     

185. E. Deshayes, R. Ladjohounlou, P. Le Fur, A. Pichard, C. Lozza, V. Boudousq, S. Sevestre, M. Jarlier, R. Kashani, J. Koch, J. Sosabowski, J. Foster, N. Chouin, F. Bruchertseifer, A. Morgenstern, P. O. Kotzki, I. Navarro-Teulon, J. P. Pouget. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer

     J Nucl Med, vol. 59, 2018, pp. 1234-1242
     

186. X. Dong, W. Yin, X. Zhang, S. Zhu, X. He, J. Yu, J. Xie, Z. Guo, L. Yan, X. Liu, Q. Wang, Z. Gu, Y. Zhao. Intelligent MoS(2) Nanotheranostic for Targeted and Enzyme-/pH-/NIR-Responsive Drug Delivery To Overcome Cancer Chemotherapy Resistance Guided by PET Imaging

     ACS Appl Mater Interfaces, vol. 10, 2018, pp. 4271-4284
     

187. D. Duan, H. Liu, Y. Xu, Y. Han, M. Xu, Z. Zhang, Z. Liu. Activating TiO(2) Nanoparticles: Gallium-68 Serves as a High-Yield Photon Emitter for Cerenkov-Induced Photodynamic Therapy

     ACS Appl Mater Interfaces, vol. 10, 2018, pp. 5278-5286
     

188. H. M. Gibson, B. N. McKnight, A. Malysa, G. Dyson, W. N. Wiesend, C. E. McCarthy, J. Reyes, W. Z. Wei, N. T. Viola-Villegas. IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy

     Cancer Res, vol. 78, 2018, pp. 5706-5717
     

189. G. Han, M. H. Spitzer, S. C. Bendall, W. J. Fantl, G. P. Nolan. Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry

     Nat Protoc, vol. 13, 2018, pp. 2121-2148
     

190. M. C. Hekman, M. Rijpkema, C. H. Muselaers, E. Oosterwijk, C. A. Hulsbergen-Van de Kaa, O. C. Boerman, W. J. Oyen, J. F. Langenhuijsen, P. F. Mulders. Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study

     Theranostics, vol. 8, 2018, pp. 2161-2170
     

191. L. Henderson, O. Neumann, C. Kaffes, R. Zhang, V. Marangoni, M. K. Ravoori, V. Kundra, J. Bankson, P. Nordlander, N. J. Halas. Routes to Potentially Safer T(1) Magnetic Resonance Imaging Contrast in a Compact Plasmonic Nanoparticle with Enhanced Fluorescence

     ACS Nano, vol. 12, 2018, pp. 8214-8223
     

192. K. E. Henry, T. R. Dilling, D. Abdel-Atti, K. J. Edwards, M. J. Evans, J. S. Lewis. Noninvasive ⁸⁹Zr-Transferrin PET Shows Improved Tumor Targeting Compared with (18)F-FDG PET in MYC-Overexpressing Human Triple-Negative Breast Cancer

     J Nucl Med, vol. 59, 2018, pp. 51-57
     

193. A. I. Jensen, G. W. Severin, A. E. Hansen, F. P. Fliedner, R. Eliasen, L. Parhamifar, A. Kjær, T. L. Andresen, J. R. Henriksen. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of (52)Mn-DOTA and ⁶⁴Cu-DOTA using radiolabelled liposomes and PET imaging

     J Control Release, vol. 269, 2018, pp. 100-109
     

194. S. K. Jones, K. Douglas, A. F. Shields, O. M. Merkel. Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model

     Biomaterials, vol. 178, 2018, pp. 183-192
     

195. G. Kılıç, B. Osman, N. Tüzmen. Application of affinity microspheres for effective SPE cleanup before the determination of sulfamerazine by HPLC

     Mater Sci Eng C Mater Biol Appl, vol. 91, 2018, pp. 55-63
     

196. H. Y. Kim, R. Li, T. S. C. Ng, G. Courties, C. B. Rodell, M. Prytyskach, R. H. Kohler, M. J. Pittet, M. Nahrendorf, R. Weissleder, M. A. Miller. Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using ⁶⁴Cu-Labeled Macrin

     ACS Nano, vol. 12, 2018, pp. 12015-12029
     

197. J. Lai, D. Lu, C. Zhang, H. Zhu, L. Gao, Y. Wang, R. Bao, Y. Zhao, B. Jia, F. Wang, Z. Yang, Z. Liu. Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy

     Biomaterials, vol. 158, 2018, pp. 1-9
     

198. H. Lajous, R. Riva, B. Lelièvre, C. Tétaud, S. Avril, F. Hindré, F. Boury, C. Jérôme, P. Lecomte, E. Garcion. Hybrid Gd(3+)/cisplatin cross-linked polymer nanoparticles enhance platinum accumulation and formation of DNA adducts in glioblastoma cell lines

     Biomater Sci, vol. 6, 2018, pp. 2386-2409
     

199. Y. Li, Y. Du, X. Liang, T. Sun, H. Xue, J. Tian, Z. Jin. EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer

     Nanoscale, vol. 10, 2018, pp. 16738-16749
     

200. N. Licciardello, S. Hunoldt, R. Bergmann, G. Singh, C. Mamat, A. Faramus, J. L. Z. Ddungu, S. Silvestrini, M. Maggini, L. De Cola, H. Stephan. Biodistribution studies of ultrasmall silicon nanoparticles and carbon dots in experimental rats and tumor mice

     Nanoscale, vol. 10, 2018, pp. 9880-9891
     

201. L. Liu, Q. Chen, C. Ruan, X. Chen, Y. Zhang, X. He, Y. Zhang, Y. Lu, Q. Guo, T. Sun, H. Wang, C. Jiang. Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity

     Theranostics, vol. 8, 2018, pp. 2974-2987
     

202. Y. Luo, E. H. Kim, C. A. Flask, H. A. Clark. Nanosensors for the Chemical Imaging of Acetylcholine Using Magnetic Resonance Imaging

     ACS Nano, vol. 12, 2018, pp. 5761-5773
     

203. D. Mandikian, H. Rafidi, P. Adhikari, P. Venkatraman, L. Nazarova, G. Fung, I. Figueroa, G. Z. Ferl, S. Ulufatu, J. Ho, C. McCaughey, J. Lau, S. F. Yu, S. Prabhu, J. Sadowsky, C. A. Boswell. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging

     MAbs, vol. 10, 2018, pp. 1269-1280
     

204. C. D. Martins, C. Da Pieve, T. A. Burley, R. Smith, D. M. Ciobota, L. Allott, K. J. Harrington, W. J. G. Oyen, G. Smith, G. Kramer-Marek. HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging

     Clin Cancer Res, vol. 24, 2018, pp. 1853-1865
     

205. K. E. Mayer, S. Mall, N. Yusufi, D. Gosmann, K. Steiger, L. Russelli, H. O. Bianchi, S. Audehm, R. Wagner, E. Bräunlein, A. Stelzl, F. Bassermann, W. Weichert, W. Weber, M. Schwaiger, C. D\'Alessandria, A. M. Krackhardt. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target

     Theranostics, vol. 8, 2018, pp. 6070-6087
     

206. V. R. N, H. S. Han, H. Lee, V. Q. Nguyen, S. Jeon, D. W. Jung, J. Lee, G. R. Yi, J. H. Park. ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy

     Nanoscale, vol. 10, 2018, pp. 9616-9627
     

207. E. Pérez, K. Bierla, G. Grindlay, J. Szpunar, J. Mora, R. Lobinski. Lanthanide polymer labels for multiplexed determination of biomarkers in human serum samples by means of size exclusion chromatography-inductively coupled plasma mass spectrometry

     Anal Chim Acta, vol. 1018, 2018, pp. 7-15
     

208. A. S. Pitek, H. Hu, S. Shukla, N. F. Steinmetz. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles

     ACS Appl Mater Interfaces, vol. 10, 2018, pp. 39468-39477
     

209. E. C. Pratt, T. M. Shaffer, Q. Zhang, C. M. Drain, J. Grimm. Nanoparticles as multimodal photon transducers of ionizing radiation

     Nat Nanotechnol, vol. 13, 2018, pp. 418-426
     

210. M. Rabyk, A. Galisova, M. Jiratova, V. Patsula, L. Srbova, L. Loukotova, J. Parnica, D. Jirak, P. Stepanek, M. Hruby. Mannan-based conjugates as a multimodal imaging platform for lymph nodes

     J Mater Chem B, vol. 6, 2018, pp. 2584-2596
     

211. F. Romero Pastrana, J. M. Thompson, M. Heuker, H. Hoekstra, C. A. Dillen, R. V. Ortines, A. G. Ashbaugh, J. E. Pickett, M. D. Linssen, N. M. Bernthal, K. P. Francis, G. Buist, M. van Oosten, G. M. van Dam, D. L. J. Thorek, L. S. Miller, J. M. van Dijl. Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe

     Virulence, vol. 9, 2018, pp. 262-272
     

212. T. H. Shin, S. Kang, S. Park, J. S. Choi, P. K. Kim, J. Cheon. A magnetic resonance tuning sensor for the MRI detection of biological targets

     Nat Protoc, vol. 13, 2018, pp. 2664-2684
     

213. G. Sun, Y. Zhang, Y. Zhang, Z. Hu, Z. Xing, S. Zhang, X. Zhang. Ratiometric quantification of β2-microglobulin antigen in human serum based on elemental labeling strategy

     Talanta, vol. 189, 2018, pp. 249-253
     

214. W. K. Tsai, K. A. Zettlitz, R. Tavaré, N. Kobayashi, R. E. Reiter, A. M. Wu. Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody

     Theranostics, vol. 8, 2018, pp. 5903-5914
     

215. G. A. Ulaner, S. K. Lyashchenko, C. Riedl, S. Ruan, P. B. Zanzonico, D. Lake, K. Jhaveri, B. Zeglis, J. S. Lewis, J. A. O\'Donoghue. First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using ⁸⁹Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer

     J Nucl Med, vol. 59, 2018, pp. 900-906
     

216. T. van der Geest, D. M. Roeleveld, B. Walgreen, M. M. Helsen, T. K. Nayak, C. Klein, M. Hegen, G. Storm, J. M. Metselaar, W. B. van den Berg, P. M. van der Kraan, P. Laverman, O. C. Boerman, M. I. Koenders. Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis

     Rheumatology (Oxford), vol. 57, 2018, pp. 737-747
     

217. H. Yamada, M. Yamashita, H. Hayashi, M. Suzuki, N. Aratani. Semiconducting π-Extended Tetrathiafulvalene Derivatives

     Chemistry, vol. 24, 2018, pp. 18601-18612
     

218. H. Yan, X. Gao, Y. Zhang, W. Chang, J. Li, X. Li, Q. Du, C. Li. Imaging Tiny Hepatic Tumor Xenografts via Endoglin-Targeted Paramagnetic/Optical Nanoprobe

     ACS Appl Mater Interfaces, vol. 10, 2018, pp. 17047-17057
     

219. Q. Yin, L. Tang, K. Cai, X. Yang, L. Yin, Y. Zhang, L. W. Dobrucki, W. G. Helferich, T. M. Fan, J. Cheng. Albumin as a Trojan Horse for polymeric nanoconjugate transendothelial transport across tumor vasculatures for improved cancer targeting

     Biomater Sci, vol. 6, 2018, pp. 1189-1200
     

220. J. T. Yoon, M. S. Longtine, B. V. Marquez-Nostra, R. L. Wahl. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with ⁸⁹Zr in Human Lymphoma Xenografts

     J Nucl Med, vol. 59, 2018, pp. 1219-1224
     

221. Y. Yoshii, M. Yoshimoto, H. Matsumoto, H. Tashima, Y. Iwao, H. Takuwa, E. Yoshida, H. Wakizaka, T. Yamaya, M. R. Zhang, A. Sugyo, S. Hanadate, A. B. Tsuji, T. Higashi. Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with ⁶⁴Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts

     Oncotarget, vol. 9, 2018, pp. 28935-28950
     

222. Y. Zhang, G. Sun, Y. Zhang, B. Huang, Z. Xing, S. Zhang, X. Zhang. Simultaneous competitive and sandwich formats multiplexed immunoassays based on ICP-MS detection

     Talanta, vol. 185, 2018, pp. 237-242
     

2014

223. A. G. Terwisscha van Scheltinga, P. Berghuis, H. H. Nienhuis, H. Timmer-Bosscha, L. Pot, S. B. Gaykema, M. N. Lub-de Hooge, J. G. Kosterink, E. G. de Vries, C. P. Schröder. Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer

     Eur J Cancer, vol. 50, 2014, pp. 2508-16
     

2011

224. W. B. Nagengast, M. N. Hooge, E. M. van Straten, S. Kruijff, A. H. Brouwers, W. F. den Dunnen, J. R. de Jong, H. Hollema, R. A. Dierckx, N. H. Mulder, E. G. de Vries, H. J. Hoekstra, G. A. Hospers. VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients

     Eur J Cancer, vol. 47, 2011, pp. 1595-602
     

2000

225. Lara L. Chappell, Kim A. Deal, Ekaterina Dadachova, and Martin W. Brechbiel. Synthesis, Conjugation, and Radiolabeling of a Novel Bifunctional Chelating Agent for 225Ac Radioimmunotherapy Applications

     Bioconjugate Chem., vol. 11, 2000, pp. 510-519, doi: 10.1021/bc990153f
     

1999

226. Kim A. Deal, Ila A. Davis, Saed Mirzadeh, Stephen J. Kennel, Martin W. Brechbiel. Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes

     , 1999, pp. 2988-2992, doi: 10.1021/jm990141f